Seres Therapeutics (MCRB) Net Shares Issued and Repurchased (2015 - 2026)

Seres Therapeutics has disclosed Net Shares Issued and Repurchased across 12 years of filings, most recently posting $586605.0 for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased rose 22.87% year-over-year to $586605.0; the TTM figure through Mar 2026 stood at $586605.0 (up 22.87% YoY), while the FY2025 annual figure was $546805.0, down 93.01% from the prior year.
• Net Shares Issued and Repurchased came in at $586605.0 for Q1 2026 at Seres Therapeutics, up from $546805.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $7.8 million in Q4 2024 to a low of $477431.0 in Q1 2025.
• Average Net Shares Issued and Repurchased over 5 years is $3.2 million, with a median of $2.5 million recorded in 2023.
• Year-over-year, Net Shares Issued and Repurchased soared 218.26% in 2024 and sank 93.01% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $4.5 million in 2022, then tumbled by 44.6% to $2.5 million in 2023, then soared by 211.64% to $7.8 million in 2024, then sank by 93.01% to $546805.0 in 2025, then advanced by 7.28% to $586605.0 in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $586605.0 in Q1 2026, $546805.0 in Q4 2025, and $477431.0 in Q1 2025.